These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 1379844)

  • 21. Recombinant human granulocyte-macrophage colony-stimulating factor in combination with standard induction chemotherapy in acute myeloid leukemia evolving from myelodysplastic syndromes: a pilot study.
    Bernell P; Kimby E; Hast R
    Leukemia; 1994 Oct; 8(10):1631-9. PubMed ID: 7934158
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment with cytosine arabinoside and granulocyte colony-stimulating factor in patients with myelodysplastic syndrome and its leukemic phase.
    Im T; Yamane T; Mugitani A; Hiyoshi M; Park K; Tatsumi N
    Int J Hematol; 1994 Oct; 60(3):215-23. PubMed ID: 7532031
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intensive chemotherapy with idarubicin, cytarabine, etoposide, and G-CSF priming in patients with advanced myelodysplastic syndrome and high-risk acute myeloid leukemia.
    Hofmann WK; Heil G; Zander C; Wiebe S; Ottmann OG; Bergmann L; Hoeffken K; Fischer JT; Knuth A; Kolbe K; Schmoll HJ; Langer W; Westerhausen M; Koelbel CB; Hoelzer D; Ganser A
    Ann Hematol; 2004 Aug; 83(8):498-503. PubMed ID: 15156346
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neutrophil recovery time and adverse side effects in acute leukemia patients treated with intensive chemotherapy and concomitant G or GM-CSF.
    Alvarado Ibarra ML; Borbolla Escoboza JR; López-Hernández MA; González-Avante CM; FloresChapa JD; Trueba Christy E; Anaya Cuellar I
    Rev Invest Clin; 1999; 51(2):77-80. PubMed ID: 10410585
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prospective randomized trial to evaluate two delayed granulocyte colony stimulating factor administration schedules after high-dose cytarabine therapy in adult patients with acute lymphoblastic leukemia.
    Hofmann WK; Seipelt G; Langenhan S; Reutzel R; Schott D; Schoeffski O; Illiger HJ; Hartmann F; Balleisen L; Franke A; Fiedler F; Huber C; Rasche H; Bergmann L; Ganser A; Pott C; Pasold R; Rudolph C; Ottmann OG; Gökbuget N; Hoelzer D
    Ann Hematol; 2002 Oct; 81(10):570-4. PubMed ID: 12424538
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Induction of Ph-negative normal clone and long-term survival by combined treatment with G-CSF plus middle dose cytosine arabinoside for patients with chronic myeloid leukemia in blastic transformation].
    Katagiri T; Miyazawa K; Uchida Y; Hayashi S; Iwama H; Shyohji N; Kawakubo K; Shimamoto T; Inatomi Y; Kuriyama Y; Yaguchi M; Nehashi Y; Ohyashiki K; Toyama K
    Rinsho Ketsueki; 1998 Dec; 39(12):1149-56. PubMed ID: 10028846
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Priming with granulocyte colony-stimulating factor--relation to high-dose cytarabine in acute myeloid leukemia.
    Büchner T; Berdel WE; Hiddemann W
    N Engl J Med; 2004 May; 350(21):2215-6. PubMed ID: 15152074
    [No Abstract]   [Full Text] [Related]  

  • 28. [A case of acute myeloblastic leukemia invaded uterine cervix-diagnosed by changes in peripheral blood after G-CSF administration].
    Ohta T; Takeuchi S; Ohara N; Deguchi M; Mochizuki M; Kitazawa S; Maeda S
    Nihon Sanka Fujinka Gakkai Zasshi; 1993 Nov; 45(11):1337-40. PubMed ID: 7505029
    [No Abstract]   [Full Text] [Related]  

  • 29. Recombinant human granulocyte-macrophage colony-stimulating factor in combination with standard induction chemotherapy in de novo acute myeloid leukemia.
    Bettelheim P; Valent P; Andreeff M; Tafuri A; Haimi J; Gorischek C; Muhm M; Sillaber C; Haas O; Vieder L
    Blood; 1991 Feb; 77(4):700-11. PubMed ID: 1993213
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytosine arabinoside (ara-C) and cis-dichlorodiammineplatinum II (cisplatin) alone and in combination: effects on acute myeloblastic leukemia blast cells in culture and in vivo.
    Wang YF; Curtis JE; Lipton J; Minkin S; McCulloch EA
    Leukemia; 1991 Jun; 5(6):522-7. PubMed ID: 1711641
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recombinant human granulocyte colony-stimulating factor in combination with continuous infusion of cytosine arabinoside for the treatment of refractory acute myelogenous leukemia.
    Goto H; Shimazaki C; Hirata T; Ashihara E; Ohkawa K; Oku N; Inaba T; Fujita N; Nakagawa M
    Acta Haematol; 1993; 89(3):144-8. PubMed ID: 7689779
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Granulocyte-colony stimulating factor (filgrastim) accelerates granulocyte recovery after intensive postremission chemotherapy for acute myeloid leukemia with aziridinyl benzoquinone and mitoxantrone: Cancer and Leukemia Group B study 9022.
    Moore JO; Dodge RK; Amrein PC; Kolitz J; Lee EJ; Powell B; Godfrey S; Robert F; Schiffer CA
    Blood; 1997 Feb; 89(3):780-8. PubMed ID: 9028308
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Contrasting in vitro effects for the combination of fludarabine, cytosine arabinoside (Ara-C) and granulocyte colony-stimulating factor (FLAG) compared with daunorubicin and Ara-C in P-glycoprotein-positive and P-glycoprotein-negative acute myeloblastic leukaemia.
    Higashi Y; Turzanski J; Pallis M; Russell NH
    Br J Haematol; 2000 Nov; 111(2):565-9. PubMed ID: 11122104
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Salvaging AML with CLAG: novel option, or more of the same?
    Wei A; Teh TC
    Leuk Res; 2011 Mar; 35(3):297-8. PubMed ID: 21074270
    [No Abstract]   [Full Text] [Related]  

  • 35. [Treatment of acute myelogenous leukemia].
    Ono R
    Nihon Naika Gakkai Zasshi; 1992 Jul; 81(7):1040-5. PubMed ID: 1383364
    [No Abstract]   [Full Text] [Related]  

  • 36. Treatment of de novo acute myelogenous leukemia with recombinant granulocyte macrophage-colony-stimulating factor in combination with standard induction chemotherapy: effect of granulocyte macrophage-colony-stimulating factor on white blood cell counts.
    Valent P; Sillaber C; Geissler K; Andreeff M; Tafuri A; Vieder L; Schulz G; Lechner K; Bettelheim P
    Med Pediatr Oncol Suppl; 1992; 2():18-22. PubMed ID: 1306881
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Granulocyte colony-stimulating factor supportive treatment following intensive chemotherapy in acute lymphocytic leukemia in first remission.
    Kantarjian HM; Estey E; O'Brien S; Anaissie E; Beran M; Pierce S; Robertson L; Keating MJ
    Cancer; 1993 Nov; 72(10):2950-5. PubMed ID: 7693325
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Chemotherapy of adult ANLL].
    Kyo T; Maehama S
    Rinsho Ketsueki; 1989 Aug; 30(8):1157-62. PubMed ID: 2601024
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The use of granulocyte colony-stimulating factor in a hemophilia patient suffering from AIDS-related NHL.
    Longo G; Viganò S; Bellesi GP; Pierotti P; Milo D; RaFanelli D; Ferrini PR
    Haematologica; 1992; 77(5):439-41. PubMed ID: 1282893
    [No Abstract]   [Full Text] [Related]  

  • 40. [Early establishment of bone marrow hypoplasia by antileukemic chemotherapy with concurrent rhG-CSF in a case of acute myelogenous leukemia complicated with intestinal perforation].
    Ono Y; Ito S; Murai K; Miyairi Y; Enomoto S; Kaneko J; Sugawara T; Numaoka H; Shimosegawa K; Utsugisawa T; Narigasawa Y; Ito T; Ishida Y; Kuriya S
    Rinsho Ketsueki; 1997 Jan; 38(1):41-6. PubMed ID: 9028160
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.